logo
Select company
Select metric
$ -63.31MConsolidated Income
VS
Market
17
Sector
33
Industry
43
History
75
$ 0.64Close
$ 0.43 - $ 2.87 52-Week Range
Ticker Information

Ticker

SGMO

Company Name

SANGAMO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SANGAMO THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SGMO - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -63.31M
3/31/2025$ -79.45M
12/31/2024$ -97.94M
9/30/2024$ -134.84M
6/30/2024$ -249.68M
3/31/2024$ -328.05M
12/31/2023$ -257.83M
9/30/2023$ -249.51M
6/30/2023$ -198.5M
3/31/2023$ -127.17M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SANGAMO THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -75.95M.
  • Over the past 5 years, SANGAMO THERAPEUTICS INC's average Cons. Inc. has been $ -166.06M.
  • The median Cons. Inc. for SANGAMO THERAPEUTICS INC during this period was $ -174.33M
  • SANGAMO THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -63.31M.
  • The lowest Cons. Inc. recorded by SANGAMO THERAPEUTICS INC in the same timeframe $ -328.05M

SANGAMO THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
ALEC : ALECTOR INC $ -115.29MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 14.44MTHTX : THERATECHNOLOGIES INC $ -6.68MAGEN : AGENUS INC $ -170.4MENTA : ENANTA PHARMACEUTICALS INC $ -92.01MPLX : PROTALIX BIOTHERAPEUTICS INC $ 6.28MSPRO : SPERO THERAPEUTICS INC $ -53.6MCSBR : CHAMPIONS ONCOLOGY INC $ 2.92MTRDA : ENTRADA THERAPEUTICS INC $ -73.35MCELU : CELULARITY INC $ -73.67M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

SGMO - Consolidated Income, Last 5 years

$ -328.05M

Minimum

Mar 31, 2024

$ -63.31M

Maximum

Jun 30, 2025

$ -166.06M

Average

$ -174.33M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M